The histone deacetylase sirtuin 2 is a new player in the regulation of platelet function

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 7, 2015, Pages 1335-1344

  Moscardo A ^a   Valles J ^a   Latorre, A ^a   Jover, R ^b,c   Santos, M T ^a  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Acetylation; Akt3 protein kinase; Blood platelet; Signal transduction; Sirtuins

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; AGK 2; CALCIUM; CAMBINOL; COLLAGEN; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; PROTEIN KINASE B; SELISISTAT; SIRTUIN 2; THROMBIN; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; SIRT2 PROTEIN, HUMAN;

ARTICLE; CALCIUM CELL LEVEL; CELL GRANULE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN ACETYLATION; REGULATORY MECHANISM; THROMBOCYTE AGGREGATION; ACETYLATION; ANTAGONISTS AND INHIBITORS; BLOOD; DRUG EFFECTS; ENZYMOLOGY; GENETICS; PHOSPHORYLATION; PROTEIN PROCESSING; SECRETION (PROCESS); SECRETORY VESICLE; SIGNAL TRANSDUCTION; THROMBOCYTE;

ACETYLATION; BLOOD PLATELETS; CALCIUM; CYTOPLASMIC GRANULES; GLYCOGEN SYNTHASE KINASE 3; HISTONE DEACETYLASE INHIBITORS; HUMANS; PHOSPHORYLATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SECRETORY VESICLES; SIGNAL TRANSDUCTION; SIRTUIN 2;

EID: 84935443262     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13004     Document Type: Article

References (24)

1. Norris KL, Lee JY, Yao TP. Acetylation goes global: the emergence of acetylation biology. Sci Signal 2009; 2: pe 76.
2. Allfrey VG, Mirsky AE. Structural modifications of histones and their possible role in the regulation of RNA synthesis. Science 1964; 144: 559.
3. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009; 325: 834-40.
4. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation? EMBO J 2000; 19: 1176-9.
5. Lundby A, Lage K, Weinert BT, Bekker-Jensen DB, Secher A, Skovgaard T, Kelstrup CD, Dmytriyev A, Choudhary C, Lundby C, Olsen JV. Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Rep 2012; 2: 419-31.
6. Lu Z, Scott I, Webster BR, Sack MN. The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology. Circ Res 2009; 105: 830-41.
7. Guan KL, Xiong Y. Regulation of intermediary metabolism by protein acetylation. Trends Biochem Sci 2011; 36: 108-16.
8. Sadoul K, Wang J, Diagouraga B, Vitte AL, Buchou T, Rossini T, Polack B, Xi X, Matthias P, Khochbin S. HDAC6 controls the kinetics of platelet activation. Blood 2012; 120: 4215-18.
9. Aslan JE, Phillips KG, Healy LD, Itakura A, Pang J, McCarty OJ. Histone deacetylase6-mediated deacetylation of alpha-tubulin coordinates cytoskeletal and signaling events during platelet activation. Am J Physiol Cell Physiol 2013; 305: C1230-9.
10. Dallavalle S, Pisano C, Zunino F. Development and therapeutic impact of HDAC6-selective inhibitors. Biochem Pharmacol 2012; 84: 756-65.
11. Heltweg B, Gatbonton T, Schuler AD, Posakony J, Li H, Goehle S, Kollipara R, Depinho RA, Gu Y, Simon JA, Bedalov A. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 2006; 66: 4368-77.
12. Mai A. Small-molecule chromatin-modifying agents: therapeutic applications. Epigenomics 2010; 2: 307-24.
13. Gertz M, Fischer F, Nguyen GT, Lakshminarasimhan M, Schutkowski M, Weyand M, Steegborn C. Ex-527 inhibits sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism. Proc Natl Acad Sci USA 2013; 110: E2772-81.
14. Santos MT, Moscardo A, Valles J, Martínez M, Piñón M, Aznar J, Broekman MJ, Marcus AJ. Participation of tyrosine phosphorylation in cytoskeletal reorganization, alpha(IIb)beta(3) integrin receptor activation, and aspirin-insensitive mechanisms of thrombin-stimulated human platelets. Circulation 2000; 102: 1924-30.
15. Moscardo A, Valles J, Pinon M, Aznar J, Martínez-Sales V, Santos MT. Regulation of cytosolic PlA2 activity by PP1/PP2A serine/threonine phosphatases in human platelets. Platelets 2006; 17: 405-15.
16. Benet M, Moya M, Donato MT, Lahoz A, Hervás D, Guzmán C, Gómez-Lechón MJ, Castell JV, Jover R. A simple transcriptomic signature able to predict drug-induced hepatic steatosis. Arch Toxicol 2014; 88: 967-82.
17. Chen J, Chan AW, To KF, Chen W, Zhang Z, Ren J, Song C, Cheung YS, Lai PB, Cheng SH, Ng MH, Huang A, Ko BC. SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinaseB/glycogen synthase kinase-3beta/beta-catenin signaling. Hepatology 2013; 57: 2287-98.
18. Dangelmaier C, Manne BK, Liverani E, Jin J, Bray P, Kunapuli SP. PDK1 selectively phosphorylates thr(308) on akt and contributes to human platelet functional responses. Thromb Haemost 2014; 111: 508-17.
19. O'Brien KA, Stojanovic-Terpo A, Hay N, Du X. An important role for Akt3 in platelet activation and thrombosis. Blood 2011; 118: 4215-23.
20. Sundaresan NR, Pillai VB, Wolfgeher D, Samant S, Vasudevan P, Parekh V, Raghuraman H, Cunningham JM, Gupta M, Gupta MP. The deacetylase SIRT1 promotes membrane localization and activation of akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signal 2011; 4: ra46.
21. Carafa V, Nebbioso A, Altucci L. Sirtuins and disease: the road ahead. Front Pharmacol 2012; 3: 4.
22. Chang HC, Guarente L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab 2014; 25: 138-45.
23. Weyrich AS, Lindemann S, Tolley ND, Kraiss LW, Dixon DA, Mahoney TM, Prescott SP, McIntyre TM, Zimmerman GA. Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost 2004; 30: 491-8.
24. Bishton MJ, Harrison SJ, Martin BP, McLaughlin N, James C, Josefsson EC, Henley KJ, Kile BT, Prince HM, Johnstone RW. Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia. Blood 2011; 117: 3658-68.